What is PharmID?
PharmID operates at the intersection of healthcare technology and regulatory compliance, primarily through its proprietary WasteWitness platform. The company utilizes a sophisticated combination of Raman spectroscopy and artificial intelligence to provide rapid, accurate validation of drug waste. This technological stack is designed to mitigate the risks associated with controlled substance diversion, a persistent challenge for hospitals and pharmacies. By automating the verification and documentation process, PharmID enables healthcare providers to maintain rigorous accountability while simultaneously reducing the administrative burden on clinical staff. The company's market position is defined by its ability to integrate seamlessly into existing hospital workflows, offering a scalable solution that addresses both patient safety and legal compliance requirements in high-stakes medical environments.
How much funding has PharmID raised?
PharmID has raised a total of $1.2M across 2 funding rounds:
Private Equity
$1M
Debt
$150K
Private Equity (2017): $1M with participation from TreeHouse Health
Debt (2020): $150K led by PPP
Key Investors in PharmID
TreeHouse Health
A strategic partner focused on accelerating the growth of healthcare startups through specialized marketing, design, and operational development services.
PPP
Public-Private Partnership
What's next for PharmID?
With the recent influx of capital, PharmID is well-positioned to accelerate its enterprise-level expansion. The strategic roadmap likely involves scaling the deployment of WasteWitness across larger hospital networks and refining its AI-driven analytics to provide deeper insights into medication disposal patterns. As regulatory requirements regarding controlled substances continue to tighten globally, PharmID is poised to capitalize on the growing demand for automated, audit-ready verification systems. Future growth will likely focus on enhancing the interoperability of its platform with electronic health records and expanding its footprint in the pharmacy sector, where the need for verifiable waste integrity is increasingly critical to operational success and risk management.
See full PharmID company page
